Yihui Pan
Overview
Explore the profile of Yihui Pan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
217
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Liang Y, Cen J, Huang Y, Fang Y, Wang Y, Shu G, et al.
Mol Cancer
. 2022 Dec;
21(1):224.
PMID: 36536414
Background: Recent studies have identified that circular RNAs (circRNAs) have an important role in cancer via their well-recognized sponge effect on miRNAs, which regulates a large variety of cancer-related genes....
12.
Wei B, Zhang T, Wang P, Pan Y, Li J, Chen W, et al.
Nat Commun
. 2022 Nov;
13(1):6909.
PMID: 36376309
The emergence of methicillin-resistant Staphylococcus aureus isolates highlights the urgent need to develop more antibiotics. ClpP is a highly conserved protease regulated by ATPases in bacteria and in mitochondria. Aberrant...
13.
Pan Y, Lu X, Shu G, Cen J, Lu J, Zhou M, et al.
Cancer Res
. 2022 Oct;
83(1):103-116.
PMID: 36264173
Significance: Extracellular vesicle-packaged IGFL2-AS1 promotes sunitinib resistance by regulating TP53INP2-triggered autophagy, implicating this lncRNA as a potential therapeutic target in renal cell carcinoma.
14.
Zhou M, Dong J, Huang J, Ye W, Zheng Z, Huang K, et al.
Adv Sci (Weinh)
. 2022 Jun;
9(22):e2105077.
PMID: 35717675
Chemoresistance is one of the leading causes of therapeutic failure in gastric cancer (GC) treatment. Recent studies have shown lncRNAs play pivotal roles in regulating GC chemoresistance. Nanocarriers delivery of...
15.
Yin Y, Pan Y, He J, Zhong H, Wu Y, Ji C, et al.
Pharmacol Res
. 2021 Nov;
175:105987.
PMID: 34798268
The most common complication during pregnancy, gestational diabetes mellitus (GDM), can cause adverse pregnancy outcomes and result in the mother and infant having a higher risk of developing type 2...
16.
Wei J, Lu J, Cao Y, Yao G, Huang Y, Zhao H, et al.
Curr Cancer Drug Targets
. 2021 Aug;
21(10):849-859.
PMID: 34382524
Background: Immune checkpoint inhibitors (ICI) have been shown to improve overall survival (OS) in clear cell renal cell carcinoma (ccRCC) patients. However, less than half of the ccRCC patients have...
17.
Cen J, Liang Y, Huang Y, Pan Y, Shu G, Zheng Z, et al.
Mol Cancer
. 2021 Jan;
20(1):19.
PMID: 33468140
Background: There is increasing evidence that circular RNAs (circRNAs) have significant regulatory roles in cancer development and progression; however, the expression patterns and biological functions of circRNAs in renal cell...
18.
Zhan Y, Pan Y, Chen B, Lu J, Zhong Z, Niu X
J Mech Behav Biomed Mater
. 2017 Jul;
75:236-243.
PMID: 28756284
Poly (ethylene glycol) diacrylate (PEGDA) derivatives are important biomedical materials. PEGDA based hydrogels have emerged as one of the popular regenerative orthopedic materials. This work aims to study the mechanical...
19.
Chen Z, Zhang J, Zhang Z, Feng Z, Wei J, Lu J, et al.
Cell Death Dis
. 2017 Jun;
8(6):e2859.
PMID: 28569782
Clear cell renal cell carcinoma (ccRCC), the most common subtype of renal cell carcinoma, can easily invade local tissues and metastasize, and is resistant to currently available treatments. Recent studies...